UniProt ID | SRC_MOUSE | |
---|---|---|
UniProt AC | P05480 | |
Protein Name | Neuronal proto-oncogene tyrosine-protein kinase Src | |
Gene Name | Src | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 541 | |
Subcellular Localization | Cell membrane . Mitochondrion inner membrane . Nucleus . Cytoplasm, cytoskeleton . Cytoplasm, perinuclear region . Localizes to focal adhesion sites following integrin engagement. Localization to focal adhesion sites requires myristoylation and the S | |
Protein Description | Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors. Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN) (Probable). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN) (By similarity). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1 (Probable). Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors. [PubMed: 9344858 Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated calcium-activated chloride channel activation (By similarity Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of GRK2, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor (Probable Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus (By similarity Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function] | |
Protein Sequence | MGSNKSKPKDASQRRRSLEPSENVHGAGGAFPASQTPSKPASADGHRGPSAAFVPPAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTRKVDVREGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGSNKSKPK ------CCCCCCCCC | 39.67 | - | |
12 | Phosphorylation | KSKPKDASQRRRSLE CCCCCCHHHHHHCCC | 34.06 | 20469934 | |
17 | Phosphorylation | DASQRRRSLEPSENV CHHHHHHCCCCCCCC | 34.96 | 26824392 | |
21 | Phosphorylation | RRRSLEPSENVHGAG HHHCCCCCCCCCCCC | 32.21 | 27742792 | |
34 | Phosphorylation | AGGAFPASQTPSKPA CCCCCCCCCCCCCCC | 34.52 | 25619855 | |
36 | Phosphorylation | GAFPASQTPSKPASA CCCCCCCCCCCCCCC | 27.34 | 25619855 | |
38 | Phosphorylation | FPASQTPSKPASADG CCCCCCCCCCCCCCC | 55.44 | 25619855 | |
42 | Phosphorylation | QTPSKPASADGHRGP CCCCCCCCCCCCCCC | 35.11 | 25619855 | |
68 | Phosphorylation | KLFGGFNSSDTVTSP CCCCCCCCCCCCCCC | 27.59 | 24925903 | |
69 | Phosphorylation | LFGGFNSSDTVTSPQ CCCCCCCCCCCCCCC | 38.10 | 24925903 | |
71 | Phosphorylation | GGFNSSDTVTSPQRA CCCCCCCCCCCCCCC | 27.86 | 24925903 | |
73 | Phosphorylation | FNSSDTVTSPQRAGP CCCCCCCCCCCCCCC | 36.46 | 25263469 | |
74 | Phosphorylation | NSSDTVTSPQRAGPL CCCCCCCCCCCCCCC | 18.07 | 25521595 | |
92 | Phosphorylation | VTTFVALYDYESRTE CEEEEEEEECCCCCC | 13.52 | 22817900 | |
98 | Phosphorylation | LYDYESRTETDLSFK EEECCCCCCEECCCC | 53.14 | - | |
100 | Phosphorylation | DYESRTETDLSFKKG ECCCCCCEECCCCCC | 41.44 | - | |
103 | Phosphorylation | SRTETDLSFKKGERL CCCCEECCCCCCCCE | 37.52 | - | |
139 | Phosphorylation | LSTGQTGYIPSNYVA CCCCCCCCCCCCCCC | 17.04 | - | |
144 | Phosphorylation | TGYIPSNYVAPSDSI CCCCCCCCCCCCCCC | 11.43 | - | |
186 | Phosphorylation | TFLVRESETTKGAYC CEEEECCCCCCCEEE | 56.60 | 18034455 | |
188 | Phosphorylation | LVRESETTKGAYCLS EEECCCCCCCEEEEE | 24.35 | - | |
192 | Phosphorylation | SETTKGAYCLSVSDF CCCCCCEEEEEHHHC | 11.55 | 22817900 | |
221 | Phosphorylation | KLDSGGFYITSRTQF ECCCCCEEEEEHHHC | 13.43 | 11572968 | |
237 | Phosphorylation | SLQQLVAYYSKHADG CHHHHHHHHHHCCCC | 10.78 | 22817900 | |
343 | Phosphorylation | VVSEEPIYIVTEYMN EECCCCEEEEEECCC | 10.47 | 22817900 | |
418 | Phosphorylation | ADFGLARLIEDNEYT HHHHHHHHHCCCCCC | 4.12 | 25731159 | |
424 | Phosphorylation | RLIEDNEYTARQGAK HHHCCCCCCCCCCCC | 16.38 | 11149930 | |
425 | Phosphorylation | LIEDNEYTARQGAKF HHCCCCCCCCCCCCC | 14.80 | 23649490 | |
431 | Malonylation | YTARQGAKFPIKWTA CCCCCCCCCCCEECC | 59.50 | 26320211 | |
444 | Phosphorylation | TAPEAALYGRFTIKS CCCCHHHHCCEEEEH | 11.09 | 20116462 | |
461 | Phosphorylation | WSFGILLTELTTKGR HHEEEEEEECCCCCC | 26.04 | 26160508 | |
464 | Phosphorylation | GILLTELTTKGRVPY EEEEEECCCCCCCCC | 21.89 | 26160508 | |
465 | Phosphorylation | ILLTELTTKGRVPYP EEEEECCCCCCCCCC | 44.09 | 26160508 | |
516 | Phosphorylation | KEPEERPTFEYLQAF CCCCCCCHHHHHHHH | 35.01 | - | |
527 | Phosphorylation | LQAFLEDYFTSTEPQ HHHHHHHHHCCCCCC | 10.20 | 21962514 | |
529 | Phosphorylation | AFLEDYFTSTEPQYQ HHHHHHHCCCCCCCC | 28.63 | 25731159 | |
535 | Phosphorylation | FTSTEPQYQPGENL- HCCCCCCCCCCCCC- | 27.65 | 11572968 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
74 | S | Phosphorylation | Kinase | CDK1 | P11440 | PSP |
144 | Y | Phosphorylation | Kinase | PDGFRB | P05622 | GPS |
424 | Y | Phosphorylation | Kinase | FAK2 | Q9QVP9 | Uniprot |
424 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
424 | Y | Phosphorylation | Kinase | SRC | P05480 | PSP |
527 | Y | Phosphorylation | Kinase | SRC | P05480 | GPS |
535 | Y | Phosphorylation | Kinase | CSK | P41240 | PSP |
535 | Y | Phosphorylation | Kinase | CSK | P41241 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SRC_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KPCE_MOUSE | Prkce | physical | 11834516 | |
DVL2_MOUSE | Dvl2 | physical | 19920076 | |
S1PR1_MOUSE | S1pr1 | physical | 21102457 | |
JAK2_MOUSE | Jak2 | physical | 21102457 | |
KHDR1_MOUSE | Khdrbs1 | physical | 15890643 | |
CBL_MOUSE | Cbl | physical | 8849724 | |
CBL_MOUSE | Cbl | physical | 9013636 | |
ENOA_MOUSE | Eno1 | physical | 9013636 | |
ENOA_MOUSE | Eno1 | physical | 14739300 | |
SHIP1_MOUSE | Inpp5d | physical | 16601135 | |
SRC_MOUSE | Src | physical | 10684249 | |
CASB_MOUSE | Csn2 | physical | 10684249 | |
P3C2A_MOUSE | Pik3c2a | physical | 10684249 | |
KHDR1_MOUSE | Khdrbs1 | physical | 10844001 | |
EFS_MOUSE | Efs | physical | 8647432 | |
DIAP1_MOUSE | Diap1 | physical | 18194650 | |
EGFR_MOUSE | Egfr | physical | 11274221 | |
FAK2_MOUSE | Ptk2b | physical | 11274221 | |
CAV3_MOUSE | Cav3 | physical | 14600260 | |
CSF1R_MOUSE | Csf1r | physical | 17420256 | |
CBL_MOUSE | Cbl | physical | 17420256 | |
CBL_MOUSE | Cbl | physical | 8635998 | |
PAXI_MOUSE | Pxn | physical | 14636584 | |
AKT1_MOUSE | Akt1 | physical | 19122674 | |
ARRB2_MOUSE | Arrb2 | physical | 19122674 | |
CBL_MOUSE | Cbl | physical | 11804588 | |
EP300_MOUSE | Ep300 | physical | 26695438 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND MASSSPECTROMETRY. | |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-192, AND MASSSPECTROMETRY. |